Diagnosis and management of systemic lupus erythematosus in children

Paediatrics and Child Health

Volumn 18, Issue 2, 2008, Pages 61-69

  Malleson, Pete ^a,b   Tekano, Jenny ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

autoimmune disease; child; prognosis; systemic lupus erythematosus; treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AUTOANTIBODY; AZATHIOPRINE; CHICKENPOX VACCINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; PREDNISONE; RITUXIMAB;

ACNE; APPETITE; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; AVASCULAR NECROSIS; BLOOD PRESSURE; BODY GROWTH; CATARACT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FATIGUE; FOLLOW UP; HUMAN; IMMUNIZATION; INFECTION SENSITIVITY; LEUKOPENIA; MOOD CHANGE; MOON FACE; MORBIDITY; MORTALITY; NEPHRITIS; OSTEOPENIA; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT REFERRAL; PROGNOSIS; RASH; SEPSIS; SIDE EFFECT; STRETCH MARK; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; URINALYSIS; WEIGHT GAIN;

EID: 39649111531     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.10.009     Document Type: Article

References (49)

1. Miettunen P.M., Ortiz-Alvarez O., Petty R.E., et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 31 (2004) 1650-1654
2. Tucker L.B., Menon S., Schaller J.G., et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34 (1995) 866-872
3. Brunner H.I., Silverman E.D., To T., et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46 (2002) 436-444
4. Petty R.E., and Laxer R.M. Systemic lupus erythematosus. In: Cassidy J.T., Petty R.E., Laxer R.M., et al. (Eds). Textbook of Pediatric Rheumatology. 5th Edn (2005), Elsevier Saunders, Philadelphia 342-391
5. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
6. Malleson P.N., Sailer M., and Mackinnon M.J. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 77 (1997) 299-304
7. Singh A.K. Lupus in the Fas lane?. J R Coll Physicians Lond 29 (1995) 475-478
8. Sneller M.C., Wang J., Dale J.K., et al. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89 (1997) 1341-1348
9. Gregersen P.K. Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond. Immunol Rev 204 (2005) 74-86
10. Baca V., Velazquez-Cruz R., Salas-Martinez G., et al. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun 7 (2006) 693-695
11. Pickering M.C., and Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 39 (2000) 133-141
12. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6 (2006) 823-835
13. Singsen B.H., Fishman L., and Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 57 (1976) 529-534
14. Schlienger R.G., Bircher A.J., and Meier C.R. Minocycline-induced lupus. A systematic review. Dermatology 200 (2000) 223-231
15. Sanders C.J., Van Weelden H., Kazzaz G.A., et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149 (2003) 131-137
16. Neiman A.R., Lee L.A., Weston W.L., et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 137 (2000) 674-680
17. Montanaro A., and Bardana Jr. E.J. Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am 17 (1991) 323-332
18. Zandman-Goddard G., and Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 1 (2002) 329-337
19. Arbuckle M.R., McClain M.T., Rubertone M.V., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003) 1526-1533
20. Sharp G.C., Irvin W.S., Tan E.M., et al. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52 (1972) 148-159
21. Watson R.M., Lane A.T., Barnett N.K., et al. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 63 (1984) 362-378
22. Hochberg M.C. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum 28 (1985) 80-86
23. Fessel W.J. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 14 (1988) 15-23
24. Pelkonen P.M., Jalanko H.J., Lantto R.K., et al. Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. J Rheumatol 21 (1994) 2143-2146
25. Malleson P.N., Fung M.Y., and Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 23 (1996) 1981-1987
26. Estes D., and Christian C.I. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50 (1971) 85-95
27. King K.K., Kornreich H.K., Bernstein B.H., et al. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 20 suppl 2 (1977) 287-294
28. DeHoratius R.J., Pillarisetty R., Messner R.P., et al. Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies. J Clin Invest 56 (1975) 1149-1154
29. Cassidy J.T., Sullivan D.B., Petty R.E., et al. Lupus nephritis and encephalopathy. Prognosis in 58 children. Arthritis Rheum 20 suppl 2 (1977) 315-322
30. Johnson A.E., Gordon C., Palmer R.G., et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38 (1995) 551-558
31. Sibbitt Jr. W.L., Brandt J.R., Johnson C.R., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29 (2002) 1536-1542
32. Pavlov-Dolijanovic S., Damjanov N., Ostojic P., et al. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients. Pediatr Dermatol 23 (2006) 437-442
33. Malleson P.N. The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol 7 (1989) 563-566
34. Malleson P., Petty R.E., Nadel H., et al. Functional asplenia in childhood onset systemic lupus erythematosus. J Rheumatol 15 (1988) 1648-1652
35. Moorthy L.N., Robbins L., Harrison M.J., et al. Quality of life in paediatric lupus. Lupus 13 (2004) 234-240
36. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N Engl J Med 324 (1991) 150-154
37. Rahman P., Gladman D.D., Urowitz M.B., et al. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26 (1999) 325-330
38. Tekano J., and Tucker L. Limiting obesity in children with rheumatic diseases requiring corticosteroid therapy. Athritis Rheum 54 (2006) S529
39. Ingster-Moati I., Crochet M., Manchon E., et al. Analysis of 925 patients on long-term hydroxychloroquine or chloroquine treatment: results of ophthalmological screening. J Fr Ophthalmol 27 (2004) 367-373
40. Lehman T.J., and Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136 (2000) 243-247
41. Silverman E.D., and Lang B. An overview of the treatment of childhood SLE. Scand J Rheumatol 26 (1997) 241-246
42. Buratti S., Szer I.S., Spencer C.H., et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 28 (2001) 2103-2108
43. Willems M., Haddad E., Niaudet P., et al. Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 148 (2006) 623-627
44. Burt R.K., Traynor A., Statkute L., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295 (2006) 527-535
45. Griffiths B., Mosca M., and Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19 (2005) 685-708
46. Gladman D.D., Goldsmith C.H., Urowitz M.B., et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27 (2000) 373-376
47. Abu-Shakra M., Press J., Varsano N., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29 (2002) 2555-2557
48. Mercado U., Acosta H., and Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56 1 (2004; Jan-Feb) 16-20
49. Vila L.M., Mayor A.M., Valentin A.H., et al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J 18 (1999) 89-94